EntWick Inc.

EntWick Inc. is a specialized electroceutical company developing non-invasive therapies for degenerative and chronic diseases using Pulsed Electromagnetic Fields (PEMF), Low-Level Light Therapy (LLLT), and electrical stimulation. Starting with ArthronPulse, our PEMF-based non-invasive electroceutical for the treatment of arthritis and joint inflammation, we are expanding our pipeline into hair loss, dermatology, blood circulation, obesity, and metabolic disorders. We have in-house capabilities in PEMF generation, 3D electromagnetic coil design, hardware, firmware, and wearable device development, supported by global patents, KC, CE, FCC, and ISO certifications. ArthronPulse received innovation awards at CES 2025 and IFA 2025. We are also exploring PEMF-based metabolic therapies targeting GLP-1-related signaling and skeletal muscle energy metabolism, while seeking global R&D, clinical, investment, and commercialization partnerships.